ORLANDO, Fla. – One of Central Florida’s largest hospital systems is reminding families a lifesaving COVID-19 treatment is offered within its medical wings.
AdventHealth said it continues to provide monoclonal antibody treatments for eligible patients, a treatment option that has resurfaced as the country grapples with the highly infectious delta variant of COVID-19.
Monoclonal antibodies can reduce the severity of COVID-19 in high-risk patients and in turn, help them avoid hospitalizations and stay out of the intensive care unit, a spokesperson with the hospital said in a news release.
Last week, Gov. Ron DeSantis announced Florida is increasing the availability of therapy and is exploring additional long-term locations across the state.
As the governor works to make the treatment more widely available, AdventHealth emphasized its approach to the treatment has been successful throughout the pandemic.
Since December 2020, AdventHealth has provided more than 3,600 monoclonal antibody treatments in Central Florida, according to a news release. Those patients were people 12 or older who tested positive for COVID-19, had mild-to-moderate symptoms for 10 or fewer days and were at high-risk for progressing severe coronavirus.
“The idea with monoclonal antibody treatments is to block that [COVID-19] protein, and stop the virus from attaching to your cells so they cannot reproduce,” said chief medical officer for AdventHealth Medical Group and OB-GYN Dr. Michael Cacciatore.
Patients must have a physician referral to receive the treatment. These are the three AdventHealth outpatient clinic locations offering the procedure in Central Florida:
- Tavares, Lake County
- Orlando, Orange County
- Orange City, Volusia County
AdventHealth says it can administer 670 monoclonal antibody treatments each week in Central Florida.